The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
.... in the way of volume but firm upward movement since the figures.
Bidders having another look ... ???
@ Gusto 1 ... just asking the Question ( to which it appears you don't know the answer)
Well, may I suggest the answer is NONE ....
As other 'posters' have pointed out there are more professional ways in which to engage in taking a 'bearish' view of a company's fortunes. I too am hopeful that this stock is in an upward trend ............ but am too long in the tooth to suggest a price (50p)!! OR any other price for that matter, by the end of this week/month. A reasoned explanation for such comments would, I'm sure, would be appreciated by all ....
This mornings statement seems to imply the the BOE wanted more than 75p.
they'll have to justify that decision ......
What price the opening ??
.... OK 930889 shares each way
Not sure but this maybe classed as a "put through" mm 2 mm so not a genuine purchase
Current price suggest that (if it comes) the bid will be 75p + 0.3 div
Current price reflects the market is a tad uncertain about the outcome ........ but only a tad !!
Walkley ..... I can't seem to find the RNS you refer to
what day was this RNS issued ?
... are you being deliberately obtuse ? The obvious point is that we are still in the midst of Covid19 and there will be other 'Leicesters'.
Why rush to purchase this supposed recovery stock. Exercise a degree of patience, wait until the future of the nation's health is more clear......... hence lessen risk. What does it matter paying a tad more if SAGA is indeed a fine recovery situation...